Hood Thabit

Has grant

Consultant Diabetologist and Honorary Senior Lecturer

Manchester University NHS Foundation Trust

United Kingdom

Research Interests

Explore related searches

Professors in United Kingdom

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Hood Thabit is a Consultant Diabetologist and Honorary Senior Lecturer at Manchester University Hospitals NHS Foundation Trust and the University of Manchester. Based in the UK, his research focuses on various aspects of diabetes care, including continuous glucose monitoring, insulin management, and the optimization of diabetes treatment strategies. His recent publications emphasize the importance of glucose interpretation and the efficacy of advanced insulin delivery systems in type 1 and type 2 diabetes management.

Recent Grants

Grant: Close

Effects of the Artificial Pancreas on Glucose Control, Cardiac Arrhythmia Risk and Sleep in Older People with Type 1 Diabetes

Open Date: 2020-01-01

Close Date:

Articles (20)

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Collaborators (14)

Jonathan Zhang Ming Lim

Honorary Senior Lecturer

University of Manchester

UNITED KINGDOM

View details

Rachel Ann Elliott

The University of Manchester

UNITED KINGDOM

View details

Professor

UNITED STATES

View details

Alison Wright

The University of Manchester

UNITED KINGDOM

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Hood Thabit

Research Interests

Explore related searches

Contact this professor

About

Recent Grants

Articles (20)

Impact of real-time glucose monitoring using FreeStyle Libre 3 on glycaemia in type 2 diabetes managed with basal insulin plus SGLT2 inhibitor and/or GLP-1 agonist

Fully closed‐loop control with ultra‐rapid versus standard insulin lispro: A randomised crossover study simulating missed meal boluses

Goodhart’s Law in Diabetes Care: The Hidden Drawbacks of Overoptimizing CGM Metrics

Glucose interpretation meaning and action: enhancing type 1 diabetes decision-making with textual descriptions

A Longitudinal Multimodal Dataset of Type 1 Diabetes

Implementation Strategies for Inpatient Continuous Glucose Monitoring-based Diabetes Management: A Systematic Review

Glucose interpretation meaning and action (GIMA): Insights to blood glucose user interface interpretation in type 1 diabetes

Large group onboarding of Omnipod 5 automated insulin delivery system—Experience from a UK secondary care diabetes service

Use of real‐time continuous glucose monitoring in non‐critical care insulin‐treated inpatients under non‐diabetes speciality teams in hospital: A pilot randomized controlled study

Impact of Ultra-Rapid Insulin on Boost and Ease-Off in the Cambridge Hybrid Closed-Loop System for Individuals With Type 1 Diabetes

Pancreas transplantation today: quo vadis?

Comparison of faster‐acting aspart with insulin aspart under conditions mimicking underestimation or missed meal boluses in type 1 diabetes using closed‐loop insulin delivery

Impact of the CamAPS FX hybrid closed‐loop insulin delivery system on sleep traits in older adults with type 1 diabetes

Patient‐reported outcomes for older adults on CamAPS FX closed loop system

Analysis of “Accuracy of a Seventh-Generation Continuous Glucose Monitoring System in Children and Adolescents With Type 1 Diabetes”

Beware the pitfalls of time below range

Impact of COVID-19 restrictions on diabetes health checks and prescribing for people with type 2 diabetes: a UK-wide cohort study involving 618 161 people in primary care

Primary prevention of cardiovascular and heart failure events with SGLT2 inhibitors, GLP-1 receptor agonists and their combination in type 2 diabetes

Real-Time Continuous Glucose Monitoring Benefits Glycemic Control in Adolescents and Young Adults With Type 1 Diabetes Irrespective of Insulin Delivery Modality: Subanalysis of the MILLENNIAL Study

Automated insulin dosing systems: Advances after a century of insulin

Collaborators (14)

Jonathan Zhang Ming Lim

Rachel Ann Elliott

Julia K. Mader

Yee Seun Cheah

Mark Evans

Robert Richardson

Martin Rutter

Simon Harper

Charlotte Boughton

Lalantha Leelarathna

Ahmed Iqbal

Titus Augustine

Angelika Gruessner

Alison Wright

Make your next move.